loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 90134 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACTAVIS ELIZABETH (4)

filter

01 TABLET, DELAYED RELEASE;ORAL (4)

filter

01 RX (4)

filter

01 DOXYCYCLINE HYCLATE (4)

filter

01 No (4)

URL Supplier Web Content
TABLET, DELAYED RE...
EQ 50MG BASE
2018-05-22
90134
DOXYCYCLINE HYCLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, DELAYED RE...
EQ 75MG BASE
2011-12-14
90134
DOXYCYCLINE HYCLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, DELAYED RE...
EQ 200MG BASE
2018-05-22
90134
DOXYCYCLINE HYCLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, DELAYED RE...
EQ 100MG BASE
2011-12-14
90134
DOXYCYCLINE HYCLAT...
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 90134

Looking for FDA Orange Book APPLICATION 90134 4

19

Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.

Regulatory Information RX

With a dosage strength EQ 50MG BASE

Dosage Form Route TABLET, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-05-22

Therapeutic Equivalence (TE) Code AB

18

Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.

Regulatory Information RX

With a dosage strength EQ 75MG BASE

Dosage Form Route TABLET, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2011-12-14

Therapeutic Equivalence (TE) Code AB

17

Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.

Regulatory Information RX

With a dosage strength EQ 200MG BASE

Dosage Form Route TABLET, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2018-05-22

Therapeutic Equivalence (TE) Code AB

16

Actavis Inc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 90134.

Regulatory Information RX

With a dosage strength EQ 100MG BASE

Dosage Form Route TABLET, DELAYED RELEASE; ORAL

Reference Listed Drug No

Approved since 2011-12-14

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY